U.S. lawmakers press Mylan on EpiPen price increases

Two senior lawmakers on the U.S. Senate’s Judiciary Committee on Monday pushed for information regarding sharp price increases for EpiPens, drug-filled injectable devices used by people to counter potentially deadly allergic reactions. Senator Chuck Grassley, chairman of the Senate Judiciary Committee, wrote Mylan Chief Executive Heather Bresch on Monday to ask how Mylan determined the price of EpiPens and what changes had been made to the product to account for the higher price. The top Democrat on the committee’s antitrust subcommittee, Senator Amy Klobuchar, urged the Federal Trade Commission on Monday to investigate the prices, citing news reports showing that the price of a pack of two EpiPens had gone from $100 in 2008 to $500 this year.

View post:
U.S. lawmakers press Mylan on EpiPen price increases